The venous side: current directions in anticoagulant therapy.
J Am Osteopath Assoc
; 100(11 Suppl): S17-21, 2000 Nov.
Article
en En
| MEDLINE
| ID: mdl-11191117
ABSTRACT
The past 10 years have seen dramatic changes in how we treat deep vein thrombosis (DVT). A decade ago, we would treat patients for 5 days with intravenous heparin and then start warfarin sodium therapy and continue administering both anticoagulants for another 5 to 7 days. In the early 1990s, we started warfarin therapy at the same time heparin was begun and decreased the hospital stay from 10 to 14 days to 5 to 7 days. With the development of low-molecular-weight heparin and the approval for use as outpatient treatment, patients are now spending 1 to 2 days in the hospital, and many times, they are not admitted. A case scenario (in italics) is integrated into this review to illustrate the cost-effective application of an evidence-based approach.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Warfarina
/
Heparina de Bajo-Peso-Molecular
/
Trombosis de la Vena
/
Anticoagulantes
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Am Osteopath Assoc
Año:
2000
Tipo del documento:
Article
País de afiliación:
Estados Unidos